A significant advance in cancer research is occurring with the use of mini-antibodies to re-engage dysfunctional p53. This essential cancer inhibitor protein is frequently lost in various forms of tumors, leading https://cruxbookmarks.com/story22038446/mini-antibodies-revive-the-p53-protein-new-potential-approach-for-cancer-therapy